| Gary Chiotti, DPM | |
|
862 Se Oak St Ste 1a, Hillsboro, OR 97123-4240 | |
| (503) 648-2200 | |
| (503) 282-8853 |
| Full Name | Gary Chiotti |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 27 Years |
| Location | 862 Se Oak St Ste 1a, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639288426 | NPI | - | NPPES |
| 297023 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP00315 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tuality Community Hospital | Hillsboro, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Good Samaritan Hospital And Medical Center | 0547179939 | 128 |
| Legacy Emanuel Hospital And Health Center | 4587573639 | 170 |
| Hillsboro Foot And Ankle Clinic, Pc | 6305935578 | 2 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Legacy Good Samaritan Hospital And Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780608216 PECOS PAC ID: 0547179939 Enrollment ID: O20031125000416 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Legacy Emanuel Hospital & Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831112358 PECOS PAC ID: 4587573639 Enrollment ID: O20040127001204 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Tuality Healthcare |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Broadway Foot & Ankle Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457498438 PECOS PAC ID: 3274631841 Enrollment ID: O20070605000305 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Hillsboro Foot & Ankle Clinic, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1790822401 PECOS PAC ID: 6305935578 Enrollment ID: O20071211000502 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Provider Name | Tuality Medical Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Chiotti, DPM 862 Se Oak Street Suite 1a, Hillsboro, OR 97123-4240 Ph: (503) 648-2200 | Gary Chiotti, DPM 862 Se Oak St Ste 1a, Hillsboro, OR 97123-4240 Ph: (503) 648-2200 |
News Archive
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
Invacare Corporation is sponsoring a bicycle expedition to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and inspire oxygen users to live active lives. The cyclist, Mark Junge, will be using the Invacare® XPO2™ Portable Oxygen Concentrator on his 816-mile trip. He will begin in New York City's Times Square on October 15, 2009, and complete the trek in Charleston, South Carolina, on November 2, 2009.
› Verified 1 days ago
Heamin T Shin, Podiatrist Medicare: Medicare Enrolled Practice Location: 2875 Ne Stucki Ave, Hillsboro, OR 97124 Phone: 800-813-2000 | |
Dr. Alicia Maureen Teausant, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2875 Ne Stucki Ave, Hillsboro, OR 97124 Phone: 503-652-2880 | |
Hillsboro Foot Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 862 Se Oak St Ste 1a, Hillsboro, OR 97123 Phone: 503-648-2200 Fax: 503-693-1004 | |
Elliot Michael, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 862 Se Oak St Ste 1a, Hillsboro, OR 97123 Phone: 503-648-2200 Fax: 503-693-1004 | |
Hillsboro Foot & Ankle Clinic, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 862 Se Oak St Ste 1a, Hillsboro, OR 97123 Phone: 503-648-2200 Fax: 503-693-1004 |